Announcements Trials
Browse Landscape

Phase

Phase 2 94Phase NA 19Phase 1 17Phase 3 13Phase 1/2 11Phase 2/3 6Phase EARLY_PHASE1 2Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Pinealoma 1Neoplasms, Germ Cell and Embryonal 1Central Nervous System Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Interventional × Immunotherapy × Clear all
NCT03387553 2026-05-07

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Completed
31 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT07017816 2026-04-29

JACOB

Children's National Research Institute

Phase EARLY_PHASE1 Recruiting
18 enrolled
CNS

Neoplasms, Germ Cell and Embryonal, Pinealoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡